Pricing Log in Create free account
Friday 6 November 2026 Export CDNA’s income statement to Excel — free account

CareDx, Inc.

CDNA Healthcare Diagnostics & Research

CareDx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $379.8 million, up 13.8% from fiscal 2024.

Revenue
+39.3%
EPS
+1,133.3%
Free cash flow
−68.6%

Quarter to September 2026, against a year earlier

76.28 0.05 −0.07%
Market cap
$4.0B
P/E
30.9×
Fwd P/E
36.2×
Dividend yield
—
F-score
5/9
Altman Z
4.14
Beneish M
−3.36
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

CareDx, Inc. (CDNA) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, CareDx, Inc. (CDNA) trades at a EV/Sales of 7.6×. Over the past ten years it has ranged from 0.0× (October 2023) to 22.0× (January 2021); the current reading is higher than 74% of that period. That is above the Diagnostics & Research industry median of 5.2× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.2× (16.40%)
FY2024 2.6× 79.00%
FY2023 1.5× 55.87%
FY2022 0.9× (86.33%)
FY2021 6.8× (58.34%)
FY2020 16.4× 139.68%
FY2019 6.9× (37.86%)
FY2018 11.0× 193.63%
FY2017 3.8× 242.24%
FY2016 1.1× (49.96%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 6.3× 163.90%
Jun 2026 2.4× 40.41%
Mar 2026 1.7× (21.97%)
Dec 2025 2.2× 36.71%
43 more quarters

Against its own ten years

Low 0.0× High 22.0×
Ten-year median 2.5×
Current reading's percentile 71

EV/Sales against peers

Company EV/Sales
VCYT Veracyte, Inc. compare 2.5×
RDNT RadNet, Inc. compare 3.0×
NEO NeoGenomics, Inc. compare 3.3×
WGS GeneDx Holdings Corp. compare 4.2×
SHC Sotera Health Company compare 5.2×
CDNA CareDx, Inc. 7.6×
BLLN BillionToOne, Inc. compare 11.0×
ADPT Adaptive Biotechnologies Corporation compare 14.6×
GRAL GRAIL, Inc. compare 29.8×
Diagnostics & Research industry median 5.2×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on CDNA